Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the first quarter of 2023. The company also provided guidance for the second quarter and fiscal 2023.
- First-quarter net sales increased 12% year-over-year on a reported basis to $3.39 billion
- Net income attributable to stockholders was $300 million or $0.21 per share, compared to $97 million or $0.07 per share last year
- Adjusted earnings, excluding one-off items, increased to $0.47 per share in the three-month period from $0.39 per share in the year-ago quarter
- The management expects net sales to increase between 6.5% and 8.5%, on a reported basis, in the second quarter
- Reported profit is expected to be in the range of $0.23 per share to $0.27 per share in the June quarter
- The guidance for adjusted second-quarter earnings per share is $0.48-$0.50
- In the full fiscal year, net sales are expected to grow in the range of 8.5% to 10.5%
Most Popular
LLY Earnings: Eli Lilly Q4 2024 profit more than doubles; revenue up 45%
Eli Lilly and Company (NYSE: LLY) Thursday reported a sharp increase in its fourth-quarter revenues. The pharmaceutical company's adjusted earnings more than doubled during the quarter. Worldwide revenue increased 45%
Ford Motor Company (F) Earnings: 4Q24 Key Numbers
Ford Motor Company (NYSE: F) reported revenue of $48.2 billion for the fourth quarter of 2024, up 5% year-over-year. GAAP net income was $1.8 billion, or $0.45 per share, compared
Philip Morris (PM) Q4 2024 Earnings: Key financials and quarterly highlights
Philip Morris International Inc. (NYSE: PM) reported its fourth quarter 2024 earnings results today. Net revenues increased 7.3% year-over-year to $9.7 billion. Organic revenue growth was also 7.3%. Net loss attributable